Interestingly, a higher MYH16 expression was associated with both worse patient OS (log-rank test, p = 0.000454) and RFS (log-rank test, p = 0.00363) in PAAD (Fig. 6F). Here, MYH16 is linked to pancreatic adenocarcinoma.